We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$39.2B
AUM Growth
+$2.5B
Cap. Flow
+$1.83B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.25%
Holding
3,494
New
280
Increased
1,537
Reduced
1,324
Closed
255

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Financials 8.97%
3 Healthcare 8.75%
4 Industrials 7.19%
5 Consumer Staples 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMP
3101
DELISTED
Cempra, Inc.
CEMP
$34K ﹤0.01%
12,170
-38,850
-76% -$471K
CVS icon
3102
CALL
CVS Health
CVS
$122B
$33K ﹤0.01%
+14,200
New +$1.15M
PFE icon
3103
CALL
Pfizer
PFE
$153B
$33K ﹤0.01%
241,682
-97,284
-29% -$2.97M
DSX icon
3104
Diana Shipping
DSX
$301M
$32K ﹤0.01%
+15,376
New +$31.5K
GERN icon
3105
Geron
GERN
$949M
$31K ﹤0.01%
14,900
+1,000
+7% +$2.11K
ALL icon
3106
CALL
Allstate
ALL
$67.5B
$30K ﹤0.01%
14,000
-2,200
-14% -$155K
HON icon
3107
CALL
Honeywell
HON
$78B
$29K ﹤0.01%
16,937
-24,574
-59% -$2.5M
SXE
3108
DELISTED
Southcross Energy Partners, L.P.
SXE
$29K ﹤0.01%
21,711
-7,000
-24% -$9.9K
PPLI
3109
CALL
People Inc
PPLI
$3.1B
$28K ﹤0.01%
101,277
-1,678
-2% -$19.6K
NOG icon
3110
Northern Oil and Gas
NOG
$2.35B
$28K ﹤0.01%
1,020
ECYT
3111
DELISTED
Endocyte, Inc. Common Stock
ECYT
$28K ﹤0.01%
+10,900
New +$31.3K
SIRI icon
3112
CALL
SiriusXM
SIRI
$10.1B
$27K ﹤0.01%
+12,200
New +$531K
SYNA icon
3113
CALL
Synaptics
SYNA
$4.15B
$27K ﹤0.01%
25,200
-300
-1% -$17.3K
SYK icon
3114
CALL
Stryker
SYK
$130B
$26K ﹤0.01%
+34,600
New +$3.98M
DRRX
3115
DELISTED
DURECT Corp
DRRX
$25K ﹤0.01%
1,880
-660
-26% -$8.43K
BAA
3116
DELISTED
Banro Corporation Common Stock
BAA
$25K ﹤0.01%
13,450
+500
+4% +$1.11K
EMN icon
3117
CALL
Eastman Chemical
EMN
$8.42B
$24K ﹤0.01%
+12,700
New +$917K
MCD icon
3118
CALL
McDonald's
MCD
$195B
$24K ﹤0.01%
10,500
-600
-5% -$70.4K
ECT
3119
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$24K ﹤0.01%
11,100
-1,000
-8% -$2.21K
CNXR
3120
DELISTED
Connecture, Inc.
CNXR
$23K ﹤0.01%
13,578
-8,403
-38% -$15.6K
FALC
3121
DELISTED
FalconStor Software Inc
FALC
$23K ﹤0.01%
50,035
+15,500
+45% +$10.7K
KBE icon
3122
CALL
State Street SPDR S&P Bank ETF
KBE
$1.71B
$22K ﹤0.01%
+16,000
New +$618K
PKG icon
3123
CALL
Packaging Corp of America
PKG
$22.8B
$22K ﹤0.01%
11,200
-11,100
-50% -$931K
TXN icon
3124
CALL
Texas Instruments
TXN
$261B
$22K ﹤0.01%
13,300
ASXC
3125
DELISTED
Asensus Surgical, Inc.
ASXC
$22K ﹤0.01%
1,286
+355
+38% +$7.28K

Similar funds

Raymond James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Raymond James & Associates held 3,494 positions worth $39.2B, up 6.8% from $36.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $1.83B of net new capital in Q4 2016, opening 280 new positions and adding to 1,537 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $76.5M trimmed.

  • Raymond James & Associates's largest Q4 2016 buy was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2016, an estimated $118M increase.
  • Raymond James & Associates's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $76.5M.
  • Raymond James & Associates fully exited Amsurg Corp in Q4 2016, selling an estimated $29.2M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $39.2B portfolio in Q4 2016.
  • Raymond James & Associates opened 280 new positions and closed 255 in Q4 2016.
  • Raymond James & Associates's portfolio value rose 6.8% quarter-over-quarter to $39.2B.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.